WaveMan · Form 4
Hanish Arnold C insider trades
> Search tickers & screens ⌘K
LIVE

Hanish Arnold C insider trades

Hanish Arnold C has filed 21 Form 4s with the SEC that we hold, for Decoy Therapeutics Inc. (DCOY) (Director) and Omeros Corp (OMER) (Director). Across all of them we count 6 purchases worth $34.6K and 6 sales worth $314.4K reported on Form 4. In the last 12 months: 1 purchase ($3.8K) and 5 sales ($282.1K). The largest single trade was a sale of 5,000 shares of Omeros Corp worth $95.1K, dated 2026-08-27. Of 3 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-11 and the latest 2026-09-02.

Decoy Therapeutics Inc. (DCOY)

Director · 11 filings · 8 purchases and sales
Trade dateCodeSharesValue as filedFiled
2019-11-25P, purchase reported on Form 43,000$10.8K2022-06-06
2020-02-11P, purchase reported on Form 44,350$5.0K2022-06-06
2020-08-21P, purchase reported on Form 44,000$3.9K2022-06-06
2021-08-10P, purchase reported on Form 47,000$6.2K2021-08-11
2022-06-03P, purchase reported on Form 428,000$5.0K2022-06-06
2025-11-20P, purchase reported on Form 45,000$3.8K2025-11-24
2025-12-30S, sale reported on Form 415$102026-01-02
2025-12-30S, sale reported on Form 412$82026-01-02

Omeros Corp (OMER)

Director · 10 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-22S, sale reported on Form 45,000$32.3K2023-05-23
2026-08-26S, sale reported on Form 45,000$92.6K2026-08-28
2026-08-27S, sale reported on Form 45,000$94.4K2026-08-28
2026-08-27S, sale reported on Form 45,000$95.1K2026-08-28
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1233253) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms